Moderna is skeptical about the effectiveness of her vaccine with Omicron

The CEO of the pharmaceutical company Moderna predicts that existing vaccines may be much less effective in dealing with variant of Omicron on coronavirus compared to earlier strains, reports Reuters.

Stefan Bansel also warned that it will take months, before pharmaceutical companies can produce large quantities of updated doses for the new variant of the virus.

He was adamant that the effectiveness of the preparations will not be the same as in the delta variant.

Modern cook booster vaccines for Omicron as well

The WHO is concerned about the spread of the strain


Bansel pointed out that the large number of Omicron mutations on the spike protein that the virus uses to infect human cells, and the rapid spread of the strain in South Africa, suggest that current vaccines may need to be modified next year.

More and more countries impose travel restrictions in an attempt to prevent the spread of the newly discovered version of COVID-19, which the World Health Organization has warned carries a very high risk from the peak of the newly infected.

Oil prices plummeted after the news. Brent crude futures fell $ 1.82, or 2.5 percent, to $ 71.62 a barrel. Oil fell about 12 percent on Friday amid fears that the highly mutated Omicron will boost global growth, hurting demand for black gold.

It is not yet clear how dangerous the new variant is and whether it is resistant to existing vaccines.

WHO: The Omicron option poses a very high global risk

Updated

WHO: The Omicron option poses a very high global risk

They call on 194 Member States to speed up vaccination



– .

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick